New guidelines address care for malignant pleural effusions

New guidelines address care for malignant pleural effusions

(HealthDay)—New clinical practice guidelines for the management of malignant pleural effusions were published in the January issue of the Annals of the American Thoracic Society.

Chakravarthy B. Reddy, M.D., from the University of Utah in Salt Lake City, and colleagues representing the American Thoracic Society, Society of Thoracic Surgeons, and Society of Thoracic Radiology conducted a systematic literature review to develop for the management of malignant pleural effusions.

The recommendations call for ultrasound imaging to guide pleural interventions and advise against therapeutic pleural interventions in . In symptomatic patients, large-volume thoracentesis is recommended to assess lung expansion. For patients with an expandable lung, no prior definitive therapy, and symptoms attributable to the effusion, indwelling pleural catheters (IPCs) or chemical pleurodesis should be used as a first-line definitive intervention. The use of IPCs over chemical pleurodesis is called for in symptomatic patients with a nonexpendable lung, failed pleurodesis, or loculated effusion. The use of either talc poudrage or talc slurry is recommended in symptomatic patients with an expandable lung undergoing talc pleurodesis.

"Because the average survival of with MPE is four to seven months, treatment should aim to relieve dyspnea in a minimally invasive manner and prevent the need for multiple procedures," the authors write.


Explore further

Study examines treatments for relieving breathing difficulties among patients with lung effusions

More information: Abstract/Full Text (subscription or payment may be required)

Copyright © 2018 HealthDay. All rights reserved.

Citation: New guidelines address care for malignant pleural effusions (2018, December 29) retrieved 17 October 2021 from https://medicalxpress.com/news/2018-12-guidelines-malignant-pleural-effusions.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
 shares

Feedback to editors